메뉴 건너뛰기




Volumn 16, Issue 10, 2002, Pages 687-688

What can we learn from cost-of-illness studies?

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; CANADA; CAREGIVER; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DISEASE SEVERITY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LEARNING; MEDICAL DECISION MAKING; MEDICAL FEE; MEDICAL RECORD; METHODOLOGY; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RESOURCE ALLOCATION;

EID: 0036813545     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/269850     Document Type: Editorial
Times cited : (3)

References (7)
  • 1
    • 0035114215 scopus 로고    scopus 로고
    • Usefuless of US cost-of-illness studies in healthcare decision making
    • Bloom BS, Bruno DJ, Maman DY, Jayadevappa R. Usefuless of US cost-of-illness studies in healthcare decision making. PharmacoEconomics 2001;19:207-13.
    • (2001) PharmacoEconomics , vol.19 , pp. 207-213
    • Bloom, B.S.1    Bruno, D.J.2    Maman, D.Y.3    Jayadevappa, R.4
  • 2
    • 0026894616 scopus 로고
    • Cost-of-illness studies. A major headache?
    • Drummond M. Cost-of-illness studies. A major headache? PharmacoEconomics 1992;2:1-4.
    • (1992) PharmacoEconomics , vol.2 , pp. 1-4
    • Drummond, M.1
  • 3
    • 0027870525 scopus 로고
    • Indirect costs in economic studies. Confronting the confusion
    • Koopmanschap MA, Rutten FFH. Indirect costs in economic studies. Confronting the confusion. PharmacoEconomics 1993;4:446-54.
    • (1993) PharmacoEconomics , vol.4 , pp. 446-454
    • Koopmanschap, M.A.1    Rutten, F.F.H.2
  • 4
    • 0029782690 scopus 로고    scopus 로고
    • The role of cost-effectiveness analysis in health and medicine
    • for the Panel on Cost-Effectiveness in Health and Medicine
    • Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC, for the Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and medicine. JAMA 1996;276:1172-7.
    • (1996) JAMA , vol.276 , pp. 1172-1177
    • Russell, L.B.1    Gold, M.R.2    Siegel, J.E.3    Daniels, N.4    Weinstein, M.C.5
  • 5
    • 0029794708 scopus 로고    scopus 로고
    • Recommendations of the panel on cost-effectiveness in health and medicine
    • for the Panel on Cost-Effectiveness in Health and Medicine
    • Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8.
    • (1996) JAMA , vol.276 , pp. 1253-1258
    • Weinstein, M.C.1    Siegel, J.E.2    Gold, M.R.3    Kamlet, M.S.4    Russell, L.B.5
  • 6
    • 0029919387 scopus 로고    scopus 로고
    • Recommendations for reporting cost-effectiveness analyses
    • for the Panel on Cost-Effectiveness in Health and Medicine
    • Siegel JE, Weinstein MC, Russell LB, Gold MR, for the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA 1996;276:1339-41.
    • (1996) JAMA , vol.276 , pp. 1339-1341
    • Siegel, J.E.1    Weinstein, M.C.2    Russell, L.B.3    Gold, M.R.4
  • 7
    • 0003013596 scopus 로고    scopus 로고
    • Presentation and use of economic evaluation results
    • Drummond M, O'Brien B, Stoddart G, Torrance GW, eds. Oxford: Oxford University Press
    • Presentation and use of economic evaluation results. In: Drummond M, O'Brien B, Stoddart G, Torrance GW, eds. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997:265-92.
    • (1997) Methods for the Economic Evaluation of Health Care Programmes , pp. 265-292


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.